P.R. Bock

2.0k total citations
30 papers, 1.4k citations indexed

About

P.R. Bock is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, P.R. Bock has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 6 papers in Biotechnology. Recurrent topics in P.R. Bock's work include Toxin Mechanisms and Immunotoxins (13 papers), Plant tissue culture and regeneration (10 papers) and Transgenic Plants and Applications (6 papers). P.R. Bock is often cited by papers focused on Toxin Mechanisms and Immunotoxins (13 papers), Plant tissue culture and regeneration (10 papers) and Transgenic Plants and Applications (6 papers). P.R. Bock collaborates with scholars based in Germany, Switzerland and Austria. P.R. Bock's co-authors include Andreas Böhle, D. Jocham, Jürgen Hanisch, E Friedel, Berthold Schneider, Harald Matthes, Emil C. Reisinger, Martin Ernst, P. Kern and M. Dietrich and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

P.R. Bock

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.R. Bock Germany	17	773	366	297	261	185	30	1.4k
Koji Izumi Japan	22	808 1.0×	147 0.4×	399 1.3×	91 0.3×	371 2.0×	102	1.7k
Xuemei Li China	19	215 0.3×	40 0.1×	192 0.6×	130 0.5×	211 1.1×	82	1.2k
Takahisa Suzuki Japan	20	298 0.4×	203 0.6×	305 1.0×	201 0.8×	233 1.3×	160	1.5k
Daniele Minardi Italy	22	199 0.3×	306 0.8×	393 1.3×	30 0.1×	123 0.7×	71	1.4k
Elisa Molinelli Italy	24	240 0.3×	39 0.1×	299 1.0×	301 1.2×	166 0.9×	105	1.4k
Kavitha Prasad India	17	236 0.3×	126 0.3×	254 0.9×	34 0.1×	85 0.5×	68	1.0k
Sujay Khandpur India	21	178 0.2×	172 0.5×	98 0.3×	169 0.6×	87 0.5×	124	1.4k
Mallika Tewari India	21	678 0.9×	18 0.0×	277 0.9×	58 0.2×	444 2.4×	104	1.3k
Jacek Michałkiewicz Poland	20	185 0.2×	23 0.1×	268 0.9×	265 1.0×	102 0.6×	74	1.1k
James E. Fitzpatrick United States	23	114 0.1×	28 0.1×	282 0.9×	117 0.4×	430 2.3×	71	1.6k

Countries citing papers authored by P.R. Bock

Since Specialization

Citations

This map shows the geographic impact of P.R. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.R. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.R. Bock more than expected).

Fields of papers citing papers by P.R. Bock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.R. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.R. Bock. The network helps show where P.R. Bock may publish in the future.

Co-authorship network of co-authors of P.R. Bock

This figure shows the co-authorship network connecting the top 25 collaborators of P.R. Bock. A scholar is included among the top collaborators of P.R. Bock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.R. Bock. P.R. Bock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bock, P.R., Jürgen Hanisch, Harald Matthes, & Kurt S. Zänker. (2014). Targeting Inflammation in Cancer-Related-Fatigue: A Rationale for Mistletoe Therapy as Supportive Care in Colorectal Cancer Patients. Inflammation & Allergy - Drug Targets. 13(2). 105–111. 19 indexed citations

Augustin, Matthias, et al.. (2011). Safety and Efficacy of the Long-term Adjuvant Treatment of Primary Intermediate- to High-Risk Malignant Melanoma (UICC/AJCC Stage II and III) with a Standardized Fermented European Mistletoe (Viscum album L.) Extract. Arzneimittelforschung. 55(1). 38–49. 34 indexed citations

Matthes, Harald, E Friedel, P.R. Bock, & K. S. Zänker. (2010). Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer. Current Molecular Medicine. 10(4). 430–439. 36 indexed citations

Madersbacher, H., Gerd Mürtz, Thomas Henne, et al.. (2009). Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study. British Journal of Urology. 103(6). 776–781. 26 indexed citations

Mürtz, Gerd, Eva Hellmis, Werner Horn, et al.. (2009). Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study. British Journal of Urology. 106(4). 550–556. 41 indexed citations

Friedel, E, Harald Matthes, P.R. Bock, & Kurt S. Zänker. (2009). Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.. PubMed. 7(4). 137–45. 28 indexed citations

Matthes, Harald, E Friedel, P.R. Bock, et al.. (2009). Supportive care in pancreatic carcinoma patients treated with a fermented mistletoe (Viscum album L.) extract.. 551–562. 2 indexed citations

Matthes, Harald, et al.. (2008). Improved supportive care in pancreatic carcinoma UICC stages I–IV patients using fermented mistletoe (Viscum album L.) extract. European Journal of Integrative Medicine. 1. 3–3. 1 indexed citations

Raedsch, R., Jürgen Hanisch, P.R. Bock, et al.. (2007). Wirksamkeit und Unbedenklichkeit des Phytopharmakons STW 5 versus Metoclopramid bei funktioneller Dyspepsie unter Praxisbedingungen - eine retrolektive Kohortenstudie. Zeitschrift für Gastroenterologie. 45(10). 1041–1048. 15 indexed citations

10.

Friedel, E, Harald Matthes, & P.R. Bock. (2007). Treatment with standardized mistletoe extract (Viscum album L.) Iscador® as a part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma. Zeitschrift für Gastroenterologie. 45(8). 1 indexed citations

11.

Madersbacher, H., S. Alloussi, Thomas Henne, et al.. (2006). ARE EFFICACY AND TOLERABILITY OF PROPIVERINE AND OXYBUTYNIN COMPARABLE IN CHILDREN WITH NEUROGENIC DETRUSOR OVERACTIVITY (NDO)? A MULTICENTRE OBSERVATIONAL COHORT STUDY. European Urology Supplements. 5(2). 298–298. 1 indexed citations

12.

Bock, P.R., et al.. (2004). Retrolective, Comparative, Epidemiological Cohort Study with Parallel Groups Design for Evaluation of Efficacyand Safety of Drugs with ‘Well-Established Use’ Experience with the Long-Term Treatment Using the European Mistletoe Extract (Viscum album L.) in Addition to Conventional Oncological Therapy in Primary, Non-Metastatic Breast Carcinoma. Complementary Medicine Research. 11(1). 23–29. 29 indexed citations

13.

Böhle, Andreas & P.R. Bock. (2004). Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology. 63(4). 682–686. 317 indexed citations

14.

Jocham, D., et al.. (2003). Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and Toxicity. The Journal of Urology. 90–95. 36 indexed citations

15.

Heyne, R, S Rickes, P.R. Bock, et al.. (2002). Non-invasive Evaluation of Activity in Inflammatory Bowel Disease by Power Doppler Sonography*. Zeitschrift für Gastroenterologie. 40(3). 171–175. 45 indexed citations

16.

Bock, P.R., et al.. (2001). Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer Chemotherapy and Pharmacology. 47(0). S38–S44. 53 indexed citations

17.

Beuth, J., et al.. (2001). Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients results of an epidemiological multicentre retrolective cohort study. Cancer Chemotherapy and Pharmacology. 47(0). S45–S54. 55 indexed citations

18.

Popiela, Tadeusz, Jan Kulig, Jürgen Hanisch, & P.R. Bock. (2001). Influence of a complementary treatment with oral enzymes on patients with colorectal cancers an epidemiological retrolective cohort study. Cancer Chemotherapy and Pharmacology. 47(0). S55–S63. 53 indexed citations

19.

Bock, P.R., et al.. (1995). Treatment of acute rejection in renal graft recipients by thymoglobuline: a retrospective multicenter analysis.. PubMed. 27(1). 1058–9. 6 indexed citations

20.

Reisinger, Emil C., P. Kern, M. Dietrich, et al.. (1990). Inhibition of HIV progression by dithiocarb. The Lancet. 335(8691). 679–682. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact